Weight loss medication isn't a one-month commitment
Blue Cross Blue Shield of Massachusetts said it is reducing coverage for GLP-1 drugs for weight loss, effective Jan
TGAb were present at a titer of 1/160 and TPOAb at 1/20480
The relative risk of cholelithiasis was 1.2, 1.3, and 1.4 in liraglutide, dulaglutide, and semaglutide with number needed to harm of 17.25, 14.69, and 10.96, respectively
As such, prioritizing research into MDSC phenotypic and functional characterization, particularly within distinct tumor microenvironments, will be essential for identifying the most relevant MDSC subsets for targeting
Regulatory milestones in countries such as China can influence investment decisions, commercialization strategies, competitive positioning, and future product launches worldwide